Page 44 - Quest Diagnostics News Today

Meeder Asset Management Inc. lessened its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 24.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 6,193 shares of the medical research company’s stock after selling 2,054 shares during the quarter. Meeder Asset Management Inc.’s holdings in Quest Diagnostics were worth […]

A decade ago, Exact Sciences launched Cologuard, impacting the fight against colorectal cancer. Its growth of 7000% is in part due to a focus on consumerization.

Olstein Capital Management L.P. lowered its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 14.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 58,000 shares of the medical research company’s stock after selling 10,000 shares during the […]

Olstein Capital Management L.P. lessened its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 14.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 58,000 shares of the medical research company’s stock after selling 10,000 shares during the quarter. Olstein Capital Management L.P.’s holdings in Quest Diagnostics were worth $7,997,000 at […]

Quest Diagnostics (NYSE:DGX – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Profitability This table compares Quest Diagnostics and […]

Quest Diagnostics (NYSE:DGX – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Insider and Institutional Ownership 88.1% of Quest […]

Boston Trust Walden Corp reduced its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,165 shares of the medical research company’s stock after selling 795 shares during the quarter. […]

Clean Yield Group increased its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,801 shares of the medical research company’s stock after purchasing an additional 475 shares during […]

Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) has received a consensus rating of “Hold” from the eleven brokerages that are presently covering the company, Marketbeat reports. Nine analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month price objective among brokers […]

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...